Amplitude Surgical

Report Publication Announcement • Nov 23, 2023

Amplitude Surgical announces its 2023-24 financial calendar

Valence, November 23, 2023, 6:00 pm CET - Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2023-24 financial calendar.

Events	Dates* for
2023-24 Q1 Sales	Thursday, November 23, 2023
2023-24 H1 Sales	Thursday, February 22, 2024
2023-24 H1 Results	Wednesday, March 20, 2024
2023-24 Q3 Sales	Thursday, April 18, 2024
2023-24 Full-Year Sales	Thursday, July 25, 2024
2023-24 Full-Year Results	Wednesday, October 23, 2024
2024-25 Q1 Sales	Thursday, November 21, 2024

* Subject to change. Press releases are published after market close.

Next press release:

H1 2023-24 sales: Thursday, February 22, 2024, after market close.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip and knee. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. As of June 30, 2023, Amplitude Surgical employed 426 people and generated sales of nearly 100.2 million euros.

Contacts:

Amplitude Surgical CFO Dimitri Borchtch finances@amplitude-surgical.com +33 (0)4 75 41 87 41

NewCap Investor Relations Thomas Grojean amplitude@newcap.eu +33 (0)1 44 71 94 94

NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 94 98